The subsequent lymph-node biopsy confirmed progression, with most tumor cells showing complete loss of AR and PSA and strong expression of neuroendocrine markers, whereas a minor component retained adenocarcinoma-like morphology and faint PSA positivity. This evidence concerns the gene AR and neoplasm.